000 | 01467 a2200469 4500 | ||
---|---|---|---|
005 | 20250513150802.0 | ||
264 | 0 | _c19981026 | |
008 | 199810s 0 0 eng d | ||
022 | _a0149-5992 | ||
024 | 7 |
_a10.2337/diacare.21.8.1371 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDubois-Laforgue, D | |
245 | 0 | 0 |
_aMutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM. _h[electronic resource] |
260 |
_bDiabetes care _cAug 1998 |
||
300 |
_a1371-2 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAmino Acid Substitution |
650 | 0 | 4 | _aAspartic Acid |
650 | 0 | 4 | _aCysteine |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xgenetics |
650 | 0 | 4 |
_aHLA Antigens _xgenetics |
650 | 0 | 4 |
_aHemochromatosis _xgenetics |
650 | 0 | 4 | _aHemochromatosis Protein |
650 | 0 | 4 | _aHistidine |
650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xgenetics |
650 | 0 | 4 | _aHomozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMajor Histocompatibility Complex |
650 | 0 | 4 | _aMembrane Proteins |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aTyrosine |
700 | 1 | _aCaillat-Zucman, S | |
700 | 1 | _aDjilali-Saiah, I | |
700 | 1 | _aLarger, E | |
700 | 1 | _aMercadier, A | |
700 | 1 | _aBoitard, C | |
700 | 1 | _aBach, J F | |
700 | 1 | _aTimsit, J | |
773 | 0 |
_tDiabetes care _gvol. 21 _gno. 8 _gp. 1371-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2337/diacare.21.8.1371 _zAvailable from publisher's website |
999 |
_c9668064 _d9668064 |